Abstract
Since the symptoms of psoriasis may be changed by treatment with selective serotonin reuptake inhibitors (SSRIs), the expression of serotonin (5-HT) and its transporter protein (SERT) in the skin of patients with psoriasis were examined employing a biotinylated-streptavidine procedure. In biopsies of such skin staining for 5-HT was limited to platelets; the expression of SERT in the keratinocytes of involved regions was redistributed; the numbers of SERT-positive dendritic or round mononuclear cells in the epidermis of involved psoriatic skin were higher than in normal healthy control skin; and the dermis of the involved skin contained higher numbers of round inflammatory cells immunostained for SERT than either non-involved psoriatic skin or normal skin. Double-immunostaining indicated that the skin cells expressing SERT also expressed CD1a, CD3 or tryptase. In addition, SERT immunostaining was co localized with caspase-3, a key regulator of apoptosis, but not with TUNEL staining. The present findings indicate that SERT might play a role in regulating apoptosis in inflammatory cells associated with psoriasis, in which case this protein might constitute a valuable therapeutic target.
Similar content being viewed by others
References
Blay SL (2006) Depression and psoriasis co morbidity. Treatment with paroxetine: two case reports. Ann Clin Psychiatry 18:271–272. doi:10.1080/10401230600948522
Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Göhlmann H, van den Wyngaert I, Coulie B (2007) Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 132:437–441. doi:10.1053/j.gastro.2006.12.014
Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell D, Sharkey KA, Gershon MD, Mawe GM, Moses PL (2004) Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126:1657–1664. doi:10.1053/j.gastro.2004.03.013
El-Nour H, Lundeberg L, Abdel-Magid N, Lonne-Rahm SB, Azmitia EC, Nordlind K (2007) Serotonergic mechanisms in human allergic contact dermatitis. Acta Derm Venereol Stockh 87:390–396. doi:10.2340/00015555-0288
Griffiths CEM, Richards HL (2001) Psychological influences in psoriasis. Clin Exp Dermatol 26:338–342. doi:10.1046/j.1365-2230.2001.00834.x
Hemlock C, Rosenthal JS, Winston A (1992) Fluoxetine-induced psoriasis. Ann Pharmacother 26:211–212
Huang J, Li G, Xiang J, Yin D, Chi R (2004) Immunohistochemical study of serotonin in lesions of psoriasis. Int J Dermatol 43:408–411. doi:10.1111/j.1365-4632.2004.02195.x
Kerckhoffs AP, Ter Linde JJM, Akkermans LMA, Samsom M (2008) Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil 20:900–907. doi:10.1111/j.1365-2982.2008.01100.x
Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G, Cola C, Zanasi M, Troisi A, Siracusano A, Lauro R, Romeo F (2006) Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 67:1760–1766
Linden DR, Chen J-X, Gershon MD, Sharkey KA, Mawe GM (2003) Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 285:G207–G216
Lonne-Rahm SB, Rickberg H, El-Nour H, Mårin P, Azmitia EC, Nordlind K (2008) Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol 22:11–18
Modell JG, Boyce S, Taylor E, Katholi C (2002) Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: a pilot study. Psychosom Med 64:835–840. doi:10.1097/01.PSY.0000021954.59258.9B
Nordlind K, Thorslund K, Lonne-Rahm SB, Mohabbati S, Berki T, Morales M, Azmitia EC (2006) Expression of serotonergic receptors in psoriatic skin. Arch Dermatol Res 298:99–106. doi:10.1007/s00403-006-0652-6
Nordlind K, Azmitia EC, Slominski A (2008) The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol 17:301–311. doi:10.1111/j.1600-0625.2007.00670.x
O’Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP (2006) A novel form of immune signalling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 107:1010–1017. doi:10.1182/blood-2005-07-2903
Osborne SF, Stafford L, Orr KGD (2002) Paroxetine-associated psoriasis. Am J Psychiatry 159:2113. doi:10.1176/appi.ajp.159.12.2113
Persico AM, Baldi A, Dell Ácqua ML, Moessner R, Murphy DL, Lesch KP, Keller F (2003) Reduced programmed cell death in brains of serotonin transporter knockout mice. Neuroreport 14:341–344. doi:10.1097/00001756-200303030-00009
Peters BP, Weissman FG, Gill MA (2000) Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm 57:645–659
Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, Wortsman J (2003) Functional activity of serotonergic and melatonergic systems expressed in the skin. J Cell Physiol 196:144–153. doi:10.1002/jcp.10287
Slominski A, Wortsman J, Tobin DJ (2005) The cutaneous serotonergic/melatonergic system: securing a place under the sun. FASEB J 19:176–194. doi:10.1096/fj.04-2079rev
Tan B, Foley P (2004) Guttate psoriasis following ecstasy ingestion. Australas J Dermatol 45:167–169. doi:10.1111/j.1440-0960.2004.00080.x
Thorslund K, Nordlind K (2007) Serotonergic drugs—a possible role in the treatment of psoriasis? Drug News Perspect 20:521–525. doi:10.1358/dnp.2007.20.8.1157614
Tsao CW, Lin YS, Cheng JT, Lin CF, Wu HT, Wu SR, Tsai WH (2008) Interferon-α-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter. J Psychopharmacol 22:753–760. doi:10.1177/0269881107082951
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thorslund, K., El-Nour, H. & Nordlind, K. The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis. Arch Dermatol Res 301, 449–457 (2009). https://doi.org/10.1007/s00403-009-0933-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-009-0933-y